|
Volumn 33, Issue 8, 2006, Pages 1091-1097
|
A phase-I clinical study of a combination therapy of vinorelbine and capecitabine in patients with advanced/recurrent breast cancer
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAPECITABINE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
NAVELBINE;
VINBLASTINE;
AGED;
ANOREXIA;
ARTICLE;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
LEUKOPENIA;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
MULTICENTER STUDY;
PHASE 1 CLINICAL TRIAL;
TUMOR RECURRENCE;
AGED;
ANOREXIA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DEOXYCYTIDINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LEUKOPENIA;
MAXIMUM TOLERATED DOSE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
VINBLASTINE;
|
EID: 33748341672
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|